Report Overview:
The Global Generic Drugs Market achieved a valuation of $411.99 Billion in 2022 and is anticipated to exceed $613.34 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 5.1% during the forecast period from 2024 to 2032.
Key Market Players:
Mylan N.V., Abbott Laboratories, ALLERGAN, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company,...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek